Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 9 | $3,639,555 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 18 Oct 2024 18:25 | NMRA | Neumora Therapeutics Inc | FUST MATTHEW K | Director | 17 Oct 2024 | Sale | 7,739 | 17.0103 | 131,643 | D |
| 18 Oct 2024 18:25 | NMRA | Neumora Therapeutics Inc | FUST MATTHEW K | Director | 18 Oct 2024 | Sale | 14,049 | 17.0346 | 239,319 | D |
| 22 Mar 2024 16:31 | CRNX | Crinetics Pharmaceuticals Inc | FUST MATTHEW K | Director | 20 Mar 2024 | Sale | 17,500 | 45.5 | 796,250 | D |
| 22 Mar 2024 16:31 | CRNX | Crinetics Pharmaceuticals Inc | FUST MATTHEW K | Director | 20 Mar 2024 | Sale | 17,500 | 43.58 | 762,650 | D |
| 22 Mar 2024 16:31 | CRNX | Crinetics Pharmaceuticals Inc | FUST MATTHEW K | Director | 20 Mar 2024 | Sale | 12,500 | 43.57 | 544,625 | D |
| 22 Mar 2024 16:31 | CRNX | Crinetics Pharmaceuticals Inc | FUST MATTHEW K | Director | 20 Mar 2024 | Sale | 12,500 | 43.57 | 544,625 | D |
| 11 Mar 2024 12:54 | RARE | Ultragenyx Pharmaceutical Inc | FUST MATTHEW K | Director | 07 Mar 2024 | Sale | 2,145 | 50.85 | 109,073 | D |
| 11 Mar 2024 12:54 | RARE | Ultragenyx Pharmaceutical Inc | FUST MATTHEW K | Director | 07 Mar 2024 | Sale | 7,500 | 50.88 | 381,600 | D |
| 11 Mar 2024 12:54 | RARE | Ultragenyx Pharmaceutical Inc | FUST MATTHEW K | Director | 07 Mar 2024 | Sale | 2,550 | 50.89 | 129,770 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)